These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32167968)

  • 21. Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary.
    Vierkoetter KR; Ayabe AR; VanDrunen M; Ahn HJ; Shimizu DM; Terada KY
    Gynecol Oncol; 2014 Oct; 135(1):81-4. PubMed ID: 25093288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic Characteristics of Endometrial Cancer in Lynch Syndrome: A French Multicenter Study.
    Rossi L; Le Frere-Belda MA; Laurent-Puig P; Buecher B; De Pauw A; Stoppa-Lyonnet D; Canlorbe G; Caron O; Borghese B; Colas C; Delhomelle H; Chabbert-Buffet N; Grandjouan S; Lecuru F; Bats AS
    Int J Gynecol Cancer; 2017 Jun; 27(5):953-960. PubMed ID: 28525912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small Bowel Adenocarcinoma Frequently Exhibits Lynch Syndrome-associated Mismatch Repair Protein Deficiency But Does Not Harbor Sporadic MLH1 Deficiency.
    Xia M; Singhi AD; Dudley B; Brand R; Nikiforova M; Pai RK
    Appl Immunohistochem Mol Morphol; 2017 Jul; 25(6):399-406. PubMed ID: 27258561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
    Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary Peritoneal Low-grade Serous Carcinoma in a Patient With Lynch Syndrome: A Case Report.
    Makiuchi S; Yoshida H; Ishikawa M; Kojima N; Kanai Y; Kato T
    Int J Gynecol Pathol; 2020 Jul; 39(4):327-332. PubMed ID: 31274699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
    Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR
    Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Founder mutation in Lynch syndrome].
    Cajal AR; Piñero TA; Verzura A; Santino JP; Solano AR; Kalfayan PG; Ferro A; Vaccaro C
    Medicina (B Aires); 2016; 76(3):180-2. PubMed ID: 27295708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
    Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
    Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome.
    Tamura K; Kaneda M; Futagawa M; Takeshita M; Kim S; Nakama M; Kawashita N; Tatsumi-Miyajima J
    Int J Clin Oncol; 2019 Sep; 24(9):999-1011. PubMed ID: 31273487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mismatch Repair Protein Expression in Endometrioid Intraepithelial Neoplasia/Atypical Hyperplasia: Should We Screen for Lynch Syndrome in Precancerous Lesions?
    Lucas E; Chen H; Molberg K; Castrillon DH; Rivera Colon G; Li L; Hinson S; Thibodeaux J; Lea J; Miller DS; Zheng W
    Int J Gynecol Pathol; 2019 Nov; 38(6):533-542. PubMed ID: 30383610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rare case of choroid plexus carcinoma that led to the diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Zhu VW; Hinduja S; Knezevich SR; Silveira WR; DeLozier CD
    Clin Neurol Neurosurg; 2017 Jul; 158():46-48. PubMed ID: 28460341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of gene-specific germline pathogenic variants on presentation of endometrial cancer in Lynch syndrome.
    Bogani G; Ricci MT; Vitellaro M; Ditto A; Chiappa V; Raspagliesi F
    Int J Gynecol Cancer; 2019 May; 29(4):705-710. PubMed ID: 30772826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients.
    Kato A; Sato N; Sugawara T; Takahashi K; Kito M; Makino K; Sato T; Shimizu D; Shirasawa H; Miura H; Sato W; Kumazawa Y; Sato A; Kumagai J; Terada Y
    Am J Surg Pathol; 2016 Jun; 40(6):770-6. PubMed ID: 26848797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients.
    Walsh MD; Cummings MC; Buchanan DD; Dambacher WM; Arnold S; McKeone D; Byrnes R; Barker MA; Leggett BA; Gattas M; Jass JR; Spurdle AB; Young J; Obermair A
    Clin Cancer Res; 2008 Mar; 14(6):1692-700. PubMed ID: 18310315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging-based definition of lower uterine segment carcinoma to improve the detection sensitivity of probable Lynch syndrome.
    Yamazaki H; Takeshita S; Todo Y; Matsumiya H; Shimada C; Minobe S; Tsuruta T; Kato H
    Jpn J Clin Oncol; 2020 Mar; 50(3):270-275. PubMed ID: 31958127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian metastasis from uveal melanoma with MLH1/PMS2 protein loss in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?
    Lobo J; Pinto C; Freitas M; Pinheiro M; Vizcaino R; Oliva E; Teixeira MR; Jerónimo C; Bartosch C
    Virchows Arch; 2017 Mar; 470(3):347-352. PubMed ID: 27915441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population.
    Ito T; Kono K; Eguchi H; Okazaki Y; Yamamoto G; Tachikawa T; Akagi K; Okada Y; Kawakami S; Morozumi M; Tamaru JI; Ishida H
    Jpn J Clin Oncol; 2020 Jan; 50(1):80-88. PubMed ID: 31665498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.
    Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM
    PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.